Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.
Sustained oxidative stress may cause hypertension, insulin resistance, metabolic syndrome, cardiovascular disease and other chronic conditions. Diets rich in natural antioxidants is associated with protective effects on the investigators health. The strategy to prevent chronic disease development and in making up the nutritional gap in the investigators diet has shifted from vitamins and minerals supplementation to whole foods and whole food products.
The objectives is to evaluate the effect of oxidative stress response of plant concentrate blends. Also, we'll confirm that vitamins, minerals and plant concentrates will not influence the biomarker expression that were monitored in the oxidative stress biomarkers. Lastly, collecting additional information on whether blends of plant concentrate have other potential health benefits.
This study will test the dose-response of blends of plant concentrates. Healthy men (n=60) with low fruit and vegetable intake will participate in a 32 day or 46 days. Each treatment duration lasts 14 days. Microarray assay and real time-polymerase chain reaction will be performed.Genes associated with oxidative stress will me monitored. The outcome of this study will help us understand how to design and develop future antioxidant related products.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Plant concentrate A | Experimental | Plant concentrate A containing Rosemary:Quercetin:Turmeric 5:3:1 Low dose (300 mg) to high dose (600 mg) |
|
| Plant concentrate B | Experimental | Plant concentrate B containing Holy Basil: Wasabi: Broccoli 5:5:1 Low dose (300 mg) to high dose (600 mg) |
|
| Plant concentrate C | Experimental | Plant concentrate C containing Holy Basil:Rosemary:Broccoli seed:Turmeric 2:2:1:1 Low dose (300 mg) to High dose (600 mg) |
|
| Plant concentrate D | Experimental | Plant concentrate D containing Rosemary:Licorice:Turmeric 1:1:1 Low dose (300 mg) to High dose (600 mg) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Plant concentrate A | Dietary Supplement | Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in urine 8-isoprostane | Change in antioxidant biomarker from baseline to day 15 | Day 1, 15 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in erythrocyte Superoxide Dismutase | Change in antioxidant biomarker from baseline to day 15 | 1, 15 |
| Change in plasma malondialdehyde | Change in antioxidant biomarker from baseline to day 15 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard Keech, M.D. | Southbay Pharma Research | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Quality of Life | Buena Park | California | 90620 | United States | ||
| Southbay Pharma Research |
Not provided
Not provided
Not provided
Not provided
Not provided
| Plant concentrate B | Dietary Supplement | Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week. |
|
| Plant concentrate C | Dietary Supplement | Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week. |
|
| Plant concentrate D | Dietary Supplement | Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week. |
|
| Day 1, 15 |
| Plasma hemoxygenase-1 | Change in antioxidant biomarker from baseline to day 15 | Day 1, 15 |
| Erythrocyte glutathione peroxidase | Change in antioxidant biomarker from baseline to day 15 | Day 1, 15 |
| Buena Park |
| California |
| 90620 |
| United States |